Oncology · 2004 · 52 citations · 24 references
MedicineCancer BiologyOncologyMetastasisOncogenesTumor ProgressionAngiogenesis In CancerAngiogenesis In Oral CancerMalignant NeoplasmsOral Cancer MetastasisOral NeoplasiaSquamous Cell CarcinomaAngiogenic BiomarkersAutocrine Growth SignalingGenome-wide CharacterizationGrowth Factor Autocrine SignalingLymph Node Metastasis BiomarkersMetastasis PatternsOncogene Expression AnalysisTumor Angiogenesis Signaling
Growth-regulated oncogene-1 (GRO-1) is an autocrine growth factor in melanoma and is a member of the CXC family of chemokines which promote chemotaxis of granulocytes and endothelia through binding to CXC receptor 2. A previous article noted that GRO-1 was upregulated in oral cancer using a genome-wide microarray approach. We have examined the expression of GRO-1 in 9 oral squamous cell carcinoma (OSCC) cell lines and 94 OSCC specimens. Using real-time quantitative polymerase chain reaction analyses, GRO-1 expressions were varied in OSCC cell lines. Of the 94 OSCC specimens, 37 (39.4%) showed GRO-1 cytoplasmic immunostaining, and microvessel density revealed a correlation between GRO-1 expression and tumor angiogenesis. GRO-1 expression was also associated with leukocyte infiltration, and lymph node metastasis. These findings suggest a possible relationship between the expression level of GRO-1 and tumor progression.
24
TNM classification of malignant tumors, fifth edition (1997)
Leslie H. Sobin, Irvin D. Fleming · Cancer · 1997 · 1K citations
Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
Zhong Chen, P. S. Malhotra, Giovana R. Thomas et al. · PubMed · 1999 · 487 citations
Life Sciences, Immunology, Oncology +17
Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma.
Doug Smith, Peter J. Polverini, S L Kunkel et al. · The Journal of Experimental Medicine · 1994 · 374 citations · Full text
Medicine, Immunology, Oncology +17